LAOPU GOLD (06181) intends to offer approximately 4.50% discount to sell 3.7118 million new H shares, with a net proceeds of approximately HKD 2.707 billion.
Old Shop Gold (06181) announced that on October 21, 2025, after trading hours on the Stock Exchange, this announcement...
LAOPU GOLD (06181) announces that on October 21, 2025 (after trading hours of the Stock Exchange), the company has entered into a placing agreement with the placing agent. According to this agreement, the placing agent has conditionally and solely (and not jointly or jointly and severally) agreed to act as the company's agent to use its best efforts to procure no fewer than 6 placees to subscribe for 3.7118 million new H shares in accordance with the terms of the placing agreement and at the price of HK$732.49 per H share.
The placing shares represent approximately 2.66% and 2.15% of the existing issued H shares and total issued shares as of the date of this announcement, and approximately 2.59% and 2.10% of the enlarged H shares and total issued shares after the issuance and placement of the placing shares (assuming that there has been no change in the total issued shares of the company from the date of this announcement to the closing date, except for the issuance and placement of the placing shares). The total nominal value of the placing shares under the placing will be RMB 37.118 million. The placing price per H share is HK$732.49, representing a discount of approximately 4.50% to the closing market price of HK$767.00 per H share on the Stock Exchange on October 21, 2025 (i.e. the placing agreement date).
The company will issue the placing shares under the general mandate. The company will apply for the listing and trading of the placing shares on the Stock Exchange.
The net proceeds from the placing, amounting to approximately HK$2.707 billion, will be used as follows: (1) 70% for inventory reserve; (2) 10% for store expansion, optimization of existing store locations, and area extension; and (3) 20% for supplementing working capital and general corporate purposes.
Related Articles

HK Stock Market Move | China Eastern Airlines (00670) up more than 4% again, rising more than 30% in the past six trading days. China Eastern's advantage in flight schedule volume to Japan and South Korea is obvious.

New Stock News | mRNA drug company Sinobioway Biotechnology plans to go public in Hong Kong or raise about $200 million.

Qwen3-VL family adds 2B and 32B models to fully cover visual language understanding scenarios.
HK Stock Market Move | China Eastern Airlines (00670) up more than 4% again, rising more than 30% in the past six trading days. China Eastern's advantage in flight schedule volume to Japan and South Korea is obvious.

New Stock News | mRNA drug company Sinobioway Biotechnology plans to go public in Hong Kong or raise about $200 million.

Qwen3-VL family adds 2B and 32B models to fully cover visual language understanding scenarios.

RECOMMEND

Why European Automakers Are Opposing Dutch Sanctions
20/10/2025

Domestic Commercial Rockets Enter Batch Launch Era: Behind the Scenes a Sixfold Cost Gap and Reusability as the Key Breakthrough
20/10/2025

Multiple Positive Catalysts Lift Tech Stocks; UBS Elevates China Tech to Most Attractive, Citing AI as Core Rationale
20/10/2025